World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Links
The origins of the coronavirus and the 2018 NIH lifting of a US ban on virus research that increases transmissibility
06/04/2021
Dr. Fauci, NIH, HHS, lifted the ban on research and manipulation of virus in lab settings in 2018 The role played by the Cambridge Group of scientists who opposed lifting the ban on gain of function research for surveillance purposes. The US public and the public in the world in India, Europe, Asia, Africa and Latin America unaware of what was going on. The devastating effects of the coronavirus in 202 and 2021 and the lack of a vaccine in 2020, lack of a vaccine in sufficient quantities in 2021. The paltry benefits of surveillance compared to the great risks of something going wrong, as pointed out by the Cambridge Group. Why was it ignored in 2018. Who makes decisions for public health in the world. Can the US make decisions for India, the people in Africa, Latin America and Asia. Does even the US public know about it, much less the public in the world at large. What power is given by the US Constitution to US government agencies on matters of public health. How are a few individuals at HHS and NIH accountable to the public in the US and the world at large.
Linked Articles
Opinion | Anthony Fauci and the Wuhan Lab
WSJ 06/03/2021
Ban on gain-of-function studies endsThe Lancet Infectious Diseases 06/04/2021
Pfizer's focus on its core pharmaceutical business in 2011-2015
05/02/2011
Rockoff's interview with Pfizer CEO, Ian Read, in which Read describes his strategy of focussing on new drug development and locating closer to hubs with large universities and research centers such as La Jolla, Cambridge, Massachusetts, and Cambridge, England. Pfizer sold its infant nutrition business to Nestle as part of this plan.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
U.S. Fed chairman Bernanke's activist interest rate policies to tackle high unemployment and central bankers from MIT
12/12/2012
A pragmatic activist focus in economic thinking shaped at the MIT economics department in Cambridge, Masachusetts. The ECB's Mario Draghi, Bank of England's Mervyn King, and Bernanke shaped their thinking at MIT. Draghi and Bernanke had the same PhD. advisor- Stanley Fischer. Factors calling for a pragmatic approach include the lack of political agreement on th deficit, the housing and foreclosure crisis effects, higher inequality and unemployment effects on the middle class, the effects of the globalized economy on working class manufacturing jobs, people dropping out of the labor foce, and lower inflation, which called for a larger focus on unemployment. Bernanke emphasized the "enormous waste in human potential and productive resources of the economy" throughout 2009-2012. Draghi emphasized the abnormal nature of excessive borrowing interest rates for Italy and Spain during the ECB's bond buying efforts in 2011-2012. Both efforts had a stabilizing effect on the economies of the U.S. and Europe during a period of political discord about future policy.
Linked Articles
Wall Street Journal 12/13/2012
MIT Forged Activist Views of Central Bank Role and Cinched Central Bankers' TiesWall Street Journal 12/12/2012
Pfizer and Merck organize R&D using international innovation hubs- 2011-2015
05/02/2011
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
